VERA BRADLEY INC (VRA) Fundamental Analysis & Valuation

NASDAQ:VRA • US92335C1062

3.48 USD
+0.1 (+2.96%)
Last: Mar 13, 2026, 02:40 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

VRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. VRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VRA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. VRA Profitability Analysis

1.1 Basic Checks

  • VRA had negative earnings in the past year.
  • In the past year VRA has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: VRA reported negative net income in multiple years.
  • In multiple years VRA reported negative operating cash flow during the last 5 years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

  • VRA has a worse Return On Assets (-40.00%) than 91.11% of its industry peers.
  • Looking at the Return On Equity, with a value of -76.11%, VRA is doing worse than 86.67% of the companies in the same industry.
Industry RankSector Rank
ROA -40%
ROE -76.11%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • Looking at the Gross Margin, with a value of 45.45%, VRA is doing worse than 60.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VRA has declined.
  • The Profit Margin and Operating Margin are not available for VRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. VRA Health Analysis

2.1 Basic Checks

  • VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • VRA has an Altman-Z score of 2.32. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • VRA has a Altman-Z score (2.32) which is in line with its industry peers.
  • VRA has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • VRA has a better Debt to Equity ratio (0.08) than 82.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACCN/A
WACC10.83%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • VRA has a Current Ratio of 2.52. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.
  • VRA's Current ratio of 2.52 is fine compared to the rest of the industry. VRA outperforms 71.11% of its industry peers.
  • VRA has a Quick Ratio of 2.52. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VRA has a worse Quick ratio (0.81) than 71.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 0.81
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. VRA Growth Analysis

3.1 Past

  • VRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.23%, which is quite good.
EPS 1Y (TTM)9.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.08%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y108.56%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.61%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. VRA Valuation Analysis

4.1 Price/Earnings Ratio

  • VRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 68.91 indicates a quite expensive valuation of VRA.
  • Based on the Price/Forward Earnings ratio, VRA is valued a bit more expensive than the industry average as 73.33% of the companies are valued more cheaply.
  • VRA is valuated expensively when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 68.91
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VRA Dividend Analysis

5.1 Amount

  • No dividends for VRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VRA Fundamentals: All Metrics, Ratios and Statistics

VERA BRADLEY INC

NASDAQ:VRA (3/13/2026, 2:40:09 PM)

3.48

+0.1 (+2.96%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-12
Earnings (Next)N/A
Inst Owners34.63%
Inst Owner Change-34.23%
Ins Owners14.93%
Ins Owner Change11.87%
Market Cap97.30M
Revenue(TTM)N/A
Net Income(TTM)-97.47M
Analysts45
Price Target5.61 (61.21%)
Short Float %6.8%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-41.61%
Min EPS beat(2)-170.03%
Max EPS beat(2)86.8%
EPS beat(4)1
Avg EPS beat(4)-209.31%
Min EPS beat(4)-556.97%
Max EPS beat(4)86.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.37%
Min Revenue beat(2)-10.65%
Max Revenue beat(2)-0.08%
Revenue beat(4)0
Avg Revenue beat(4)-5.85%
Min Revenue beat(4)-10.65%
Max Revenue beat(4)-0.08%
Revenue beat(8)0
Avg Revenue beat(8)-8.3%
Revenue beat(12)1
Avg Revenue beat(12)-6.44%
Revenue beat(16)2
Avg Revenue beat(16)-5.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-39.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 68.91
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.05
Fwd EY1.45%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS10.18
BVpS4.58
TBVpS4.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40%
ROE -76.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.45%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
F-Score3
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -111.96%
Cap/Sales 2.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 0.81
Altman-Z 2.32
F-Score3
WACC10.83%
ROIC/WACCN/A
Cap/Depr(3y)68.99%
Cap/Depr(5y)55.33%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130%
EPS Next Y108.56%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.08%
Revenue Next Year1.61%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-279.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-69.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.7%
OCF growth 3YN/A
OCF growth 5YN/A

VERA BRADLEY INC / VRA FAQ

Can you provide the ChartMill fundamental rating for VERA BRADLEY INC?

ChartMill assigns a fundamental rating of 2 / 10 to VRA.


What is the valuation status of VERA BRADLEY INC (VRA) stock?

ChartMill assigns a valuation rating of 1 / 10 to VERA BRADLEY INC (VRA). This can be considered as Overvalued.


How profitable is VERA BRADLEY INC (VRA) stock?

VERA BRADLEY INC (VRA) has a profitability rating of 1 / 10.


Can you provide the financial health for VRA stock?

The financial health rating of VERA BRADLEY INC (VRA) is 5 / 10.